Reliable business case for repurposing of existing medicines requires key changes in government policies

Samuel J. de Visser; Sibren van den Berg; Arend Mosterd; Donald C. Lo

doi:10.1016/j.drudis.2024.104096

Reliable business case for repurposing of existing medicines requires key changes in government policies

Samuel J. de Visser^*
, Sibren van den Berg
, Arend Mosterd
, Donald C. Lo

^*Corresponding author for this work

Centre for Future Affordable & Sustainable Therapy Development (FAST)
University of Amsterdam
Meander Medisch Centrum
EATRIS ERIC

Research output: Contribution to journal › Editorial › Academic › peer-review

21 Downloads (Pure)

Original language	English
Article number	104096
Journal	Drug discovery today
Volume	29
Issue number	9
DOIs	https://doi.org/10.1016/j.drudis.2024.104096
Publication status	Published - 1 Sept 2024

Access to Document

10.1016/j.drudis.2024.104096

Reliable-business-case-for-repurposing-of-existing-medicines-requires-key-changes-in-government-policies.pdfFinal published version, 239 KBLicence: Taverne

Cite this

@article{048e6099740942319481b7377140d33c,

title = "Reliable business case for repurposing of existing medicines requires key changes in government policies",

author = "\{de Visser\}, \{Samuel J.\} and \{van den Berg\}, Sibren and Arend Mosterd and Lo, \{Donald C.\}",

year = "2024",

month = sep,

day = "1",

doi = "10.1016/j.drudis.2024.104096",

language = "English",

volume = "29",

journal = "Drug discovery today",

issn = "1359-6446",

publisher = "Elsevier Limited",

number = "9",

}

TY - JOUR

T1 - Reliable business case for repurposing of existing medicines requires key changes in government policies

AU - de Visser, Samuel J.

AU - van den Berg, Sibren

AU - Mosterd, Arend

AU - Lo, Donald C.

PY - 2024/9/1

Y1 - 2024/9/1

UR - https://www.scopus.com/pages/publications/85199317051

U2 - 10.1016/j.drudis.2024.104096

DO - 10.1016/j.drudis.2024.104096

M3 - Editorial

C2 - 38992418

SN - 1359-6446

VL - 29

JO - Drug discovery today

JF - Drug discovery today

IS - 9

M1 - 104096

ER -

Reliable business case for repurposing of existing medicines requires key changes in government policies

Access to Document

Other files and links

Cite this